Radius Health files for $86 mn IPO [BIOTECH]

Radius Health is planning to list on NASDAQ for its $86 mn IPO. The biotech company is the fifth in the sector to set IPO terms this year, according to Renaissance Capital: two have gone public, two are set to price this week and one has pulled its IPO. The lead underwriters on the Radius Health IPO are UBS and Leerink Swann. The company plans to trade under the symbol RDUS.

Click here for FREE email alerts from Inside IPO >>

Source: Renaissance Capital